FGL2
Fibroleukin
Also known as: FGL2_HUMAN, pT49, T49
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14314
- Gene
- FGL2
- Ensembl
- ENSG00000127951
- Chromosome
- 7
- Canonical length
- 439 aa
- Protein class
- Plasma proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene is a secreted protein that is similar to the beta- and gamma-chains of fibrinogen. The carboxyl-terminus of the encoded protein consists of the fibrinogen-related domains (FRED). The encoded protein forms a tetrameric complex which is stabilized by interchain disulfide bonds. This protein may play a role in physiologic functions at mucosal sites. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
439 residues, UniProt reviewed canonical sequence.
>Q14314|FGL2
1 MKLANWYWLS SAVLATYGFL VVANNETEEI KDERAKDVCP VRLESRGKCE EAGECPYQVS
61 LPPLTIQLPK QFSRIEEVFK EVQNLKEIVN SLKKSCQDCK LQADDNGDPG RNGLLLPSTG
121 APGEVGDNRV RELESEVNKL SSELKNAKEE INVLHGRLEK LNLVNMNNIE NYVDSKVANL
181 TFVVNSLDGK CSKCPSQEQI QSRPVQHLIY KDCSDYYAIG KRSSETYRVT PDPKNSSFEV
241 YCDMETMGGG WTVLQARLDG STNFTRTWQD YKAGFGNLRR EFWLGNDKIH LLTKSKEMIL
301 RIDLEDFNGV ELYALYDQFY VANEFLKYRL HVGNYNGTAG DALRFNKHYN HDLKFFTTPD
361 KDNDRYPSGN CGLYYSSGWW FDACLSANLN GKYYHQKYRG VRNGIFWGTW PGVSEAHPGG
421 YKSSFKEAKM MIRPKHFKPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FGL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 154 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 154 nTPM
- spleen: 153 nTPM
- appendix: 84 nTPM
- urinary bladder: 69 nTPM
- small intestine: 66 nTPM
- rectum: 54 nTPM
Single-cell type
- schwann cells: 614 nCPM
- kupffer cells: 591 nCPM
- monocytes: 590 nCPM
- cdc: 536 nCPM
- macrophages: 448 nCPM
- monocyte progenitors: 140 nCPM
Immune cell
- non-classical monocyte: 382 nTPM
- intermediate monocyte: 380 nTPM
- neutrophil: 295 nTPM
- classical monocyte: 256 nTPM
- eosinophil: 227 nTPM
- total PBMC: 174 nTPM
Brain region
- white matter: 21 nTPM
- medulla oblongata: 17 nTPM
- midbrain: 13 nTPM
- spinal cord: 13 nTPM
- choroid plexus: 13 nTPM
- hypothalamus: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.58
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of defense response to virus
- negative regulation of dendritic cell antigen processing and presentation
- negative regulation of memory T cell differentiation
- T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell
- negative regulation of macrophage antigen processing and presentation
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FGL2 as an antibody target. Whether an autoantibody or antibody against FGL2 could matter depends on whether native FGL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FGL2 is annotated as secreted, so native FGL2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label FGL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...